TPST Insider Trading

Net Buying · 180d
Open-Market Buys (180d)
$1.0M
1 insiders
Open-Market Sells (180d)
$0
0 insiders
Net Insider Flow
$1.0M
open market, 180d
Reporting Insiders
1
2 P/S transactions
Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Recent Form 4 Transactions

93 shown
DateInsiderRoleActionSharesPriceValue
Jun 4, 2026Richey William DrakeDirectorGrant(A)25K$0
Jun 4, 2026Yee John D.DirectorGrant(A)25K$0
Mar 31, 2026Maestas NicholasChief Financial OfficerGrant(A)140K$0
Mar 31, 2026Trojanowski JustinCorporate ControllerGrant(A)22K$0
Mar 24, 2026Angel MatthewCEO and President, Director, 10% OwnerBuy(P)231K$2.16$500K
Mar 24, 2026Angel MatthewCEO and President, Director, 10% OwnerBuy(P)231K$2.16$500K
Mar 24, 2026Angel MatthewCEO and President, Director, 10% OwnerBuy(P)231K
Mar 24, 2026Angel MatthewCEO and President, Director, 10% OwnerBuy(P)231K
Feb 4, 2026Angel MatthewCEO and President, Director, 10% OwnerGrant(A)270K$0
Jan 27, 2026Pellizzari Christine ADirectorGrant(A)1K$0
Jan 27, 2026Nichol GeoffreyDirectorGrant(A)1K$0
Jan 27, 2026Raab MichaelDirectorGrant(A)1K$0
Jan 27, 2026Simantov RonitDirectorGrant(A)1K$0
Jan 2, 2025Maestas NicholasChief Financial OfficerGrant(A)200K$0
Jan 2, 2025Whiting SamuelChief Medical OfficerGrant(A)270K$0
Jan 2, 2025Brady Stephen RPresident and CEO, DirectorGrant(A)550K$0
Jan 2, 2025Trojanowski JustinCorporate ControllerGrant(A)30K$0
Aug 12, 2024Versant Venture Capital VI, L.P.10% OwnerSell(S)388K$1.10$427K
Aug 8, 2024Versant Venture Capital VI, L.P.10% OwnerSell(S)400K$1.35$540K
Jul 3, 2024Brady Stephen RPresident and CEO, DirectorBuy(P)35K$2.11$74K
Jul 2, 2024Whiting SamuelChief Medical OfficerBuy(P)5K$2.13$10K
Jun 28, 2024Trojanowski JustinCorporate ControllerBuy(P)8K$2.16$16K
Jun 13, 2024Raab MichaelDirectorGrant(A)16K$0
Jun 13, 2024Simantov RonitDirectorGrant(A)16K$0
Jun 13, 2024Nichol GeoffreyDirectorGrant(A)16K$0
Jun 13, 2024Pellizzari Christine ADirectorGrant(A)16K$0
Jan 3, 2024Maestas NicholasVP of Strategy and FinanceGrant(A)40K$0
Jan 3, 2024Trojanowski JustinPrincipal Accounting OfficerGrant(A)27K$0
Jan 3, 2024Whiting SamuelChief Medical OfficerGrant(A)100K$0
Jan 3, 2024Brady Stephen RPresident and CEO, DirectorGrant(A)250K$0
Oct 11, 2023Maestas NicholasVP of Strategy and FinanceGrant(A)100K$0
Oct 11, 2023Whiting SamuelChief Medical OfficerGrant(A)325K$0
Oct 11, 2023Trojanowski JustinCorporate ControllerGrant(A)55K$0
Oct 11, 2023Brady Stephen RPresident and CEO, DirectorGrant(A)725K$0
Jun 15, 2023Simantov RonitDirectorGrant(A)8K$0
Jun 15, 2023Pellizzari Christine ADirectorGrant(A)8K$0
Jun 15, 2023Nichol GeoffreyDirectorGrant(A)8K$0
Jun 15, 2023Raab MichaelDirectorGrant(A)8K$0
Jan 3, 2023Trojanowski JustinCorporate ControllerGrant(A)20K$0
Jan 3, 2023Maestas NicholasVP of Strategy and FinanceGrant(A)38K$0
Jan 3, 2023Brady Stephen RChief Executive Officer, DirectorGrant(A)177K$0
Jan 3, 2023Dubensky Thomas W.President, DirectorGrant(A)103K$0
Jan 3, 2023Whiting SamuelChief Medical OfficerGrant(A)70K$0
Oct 3, 2022Trojanowski JustinCorporate ControllerGrant(A)3K$0
Jun 21, 2022Brady Stephen RChief Executive Officer, DirectorGrant(A)174K$0
Jun 21, 2022Dubensky Thomas W.President, DirectorGrant(A)88K$0
Jun 21, 2022Whiting SamuelChief Medical OfficerGrant(A)56K$0
Jun 21, 2022Maestas NicholasVP of Strategy and FinanceGrant(A)51K$0
Jun 21, 2022Lorenzo PierreCorporate ControllerGrant(A)8K$0
Jun 17, 2022Raab MichaelDirectorGrant(A)4K$0
Jun 17, 2022Simantov RonitDirectorGrant(A)4K$0
Jun 17, 2022Woiwode ThomasDirectorGrant(A)4K$0
Jun 17, 2022Nichol GeoffreyDirectorGrant(A)4K$0
Jun 17, 2022Pellizzari Christine ADirectorGrant(A)4K$0
Apr 29, 2022Woiwode ThomasDirector, 10% OwnerBuy(P)2.1M$2.36$5.0M
Jan 7, 2022Dubensky Thomas W.President, DirectorBuy(P)2K$4.78$10K
Jan 6, 2022Whiting SamuelChief Medical OfficerBuy(P)2K$4.80$8K
Jan 4, 2022Dubensky Thomas W.President, DirectorGrant(A)53K$0
Jan 4, 2022Brady Stephen RChief Executive Officer, DirectorGrant(A)95K$0
Jan 4, 2022Whiting SamuelChief Medical OfficerGrant(A)29K$0
Jan 4, 2022Maestas NicholasVP of Strategy and FinanceGrant(A)20K$0
Jan 4, 2022Lorenzo PierreCorporate ControllerGrant(A)7K$0
Sep 21, 2021Raab MichaelDirectorGrant(A)7K$0
Aug 6, 2021Simantov RonitDirectorGrant(A)7K$0
Jul 12, 2021Maestas NicholasVP of Strategy and FinanceGrant(A)23K$0
Jul 1, 2021Xu StellaDirectorGrant(A)7K$0
Jul 1, 2021Woiwode ThomasDirectorGrant(A)7K$0
Jul 1, 2021Pellizzari Christine ADirectorGrant(A)7K$0
Jul 1, 2021Nichol GeoffreyDirectorGrant(A)7K$0
Jun 25, 2021Lorenzo PierreCorporate ControllerGrant(A)53
Jun 25, 2021Lorenzo PierreCorporate ControllerGrant(A)5K
Jun 25, 2021Lorenzo PierreCorporate ControllerGrant(A)49K
Jun 25, 2021Lorenzo PierreCorporate ControllerGrant(A)1K
Jun 25, 2021Woiwode ThomasDirector, 10% OwnerGrant(A)7K
Jun 25, 2021Woiwode ThomasDirector, 10% OwnerGrant(A)1.2M
Jun 25, 2021Woiwode ThomasDirector, 10% OwnerGrant(A)998K
Jun 25, 2021Brady Stephen RChief Executive Officer, DirectorGrant(A)70K
Jun 25, 2021Brady Stephen RChief Executive Officer, DirectorGrant(A)8K
Jun 25, 2021Brady Stephen RChief Executive Officer, DirectorGrant(A)110K
Jun 25, 2021Brady Stephen RChief Executive Officer, DirectorGrant(A)2.0M
Jun 25, 2021Dubensky Thomas W.President, DirectorGrant(A)111K
Jun 25, 2021Dubensky Thomas W.President, DirectorGrant(A)46K
Jun 25, 2021Dubensky Thomas W.President, DirectorGrant(A)1.0M
Jun 25, 2021Dubensky Thomas W.President, DirectorGrant(A)8K
Jun 25, 2021Dubensky Thomas W.President, DirectorGrant(A)36K
Jun 25, 2021Raab MichaelDirectorGrant(A)10K
Jun 25, 2021Raab MichaelDirectorGrant(A)17K
Jun 25, 2021Raab MichaelDirectorGrant(A)5K
Jun 25, 2021Xu StellaDirectorGrant(A)580K
Jun 25, 2021Whiting SamuelChief Medical OfficerGrant(A)201
Jun 25, 2021Whiting SamuelChief Medical OfficerGrant(A)540K
Jun 25, 2021Whiting SamuelChief Medical OfficerGrant(A)62K
Jun 25, 2021Whiting SamuelChief Medical OfficerGrant(A)3K

Data Source

Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.

Coverage: Form 4 filings indexed 2006-01-022026-08-28. Earlier history is backfilling; this window widens as it deepens.

Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).

Keep exploring

Connected pages for TPST